SCHEMBL8000358

SCHEMBL8000358

C=C(O)C(N)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15160619 1.00
SCHEMBL13018309 0.80
SCHEMBL13242309 0.77
SCHEMBL12670153 0.77
SCHEMBL21162907 0.74
SCHEMBL12729967 0.74
SCHEMBL8000603 0.71
SCHEMBL14886270 0.71
Valine SCHEMBL28760105 0.71 SLC7A5 (0.88)
Valine SCHEMBL20981544 0.71 SLC7A5 (0.88)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023008895-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME (주)피엔에이치테크 2023-02-02 WO disclosed
US-20220356303-A1 LIPIDATED POLY(AMINO ACID) NANOSTRUCTURES THE CURATORS OF THE UNIVERSITY OF MISSOURI 2022-11-10 US disclosed
WO-2009111442-A1 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2009-09-11 WO disclosed
WO-2006050991-A1 COMPOUNDS HAVING ACTIVITY AT NK3 RECEPTOR AND USES THEREOF IN MEDICINE SMITHKLINE BEECHAM CORPORATION (US) 2006-05-18 WO disclosed